Back to top

Image: Bigstock

Zacks.com highlights: HollyFrontier, Amedisys, MGM Growth Properties, Louisiana-Pacific and Houlihan Lokey

Read MoreHide Full Article

For Immediate Release

Chicago, IL – July 24, 2018 - Stocks in this week’s article include: HollyFrontier Corp. , Amedisys Inc. (AMED - Free Report) , MGM Growth Properties LLC , Louisiana-Pacific Corp. (LPX - Free Report) and Houlihan Lokey, Inc. (HLI - Free Report) .

Screen of the Week of Zacks Investment Research:

Bet on These 5 Low-Leverage Stocks for Safe Returns

Leverage, in particular financial leverage, is a popular investment strategy of using borrowed capital by corporations to finance their operations as well as expand the same. While there exist options for equity financing, historically, debt financing has achieved more popularity when compared to equity financing.

This is because, on availing debt financing, the company’s equity does not get diluted as a result of issuing more shares of the stock. In other words, the borrower has no claim in the company’s shares.

Another perk of debt financing is that the interest on debt is tax deductible.

Interestingly, the United States — the world’s richest economy — is the biggest borrower as well. In fact, according to the fiscal 2019 federal budget, at the end of fiscal 2018, gross U.S. federal government debt is estimated to be $21.09 trillion, more than double the debt load in the last decade.

Yet, no one voluntarily wishes to be part of a debt-ridden nation. This is because debt brings with it the burden of interest payments.

Then again, this should not dissuade one from investing in U.S. stocks. After all, in spite of such high debt levels, the United States remains the largest economy in the world in terms of GDP, representing a quarter share of the global economy per the latest World Bank figures.

The problem arises when the amount of debt a company bears becomes exorbitant. In fact, companies with high debt loads are more vulnerable during economic downturns and can even go bankrupt.

Empirically it has been found that in periods of low interest rates, debt financing has gained more traction. At present, with robust parameters supporting growth across the U.S. economy and thereby favoring interest rate hike, the market is not very attractive more hugely burdened companies. So, the crux of safe investment lies in identifying low leverage stocks as debt-free stocks are rare.

Therefore, to safeguard one’s portfolio from losses, an investor should prudently determine whether the stock’s debt level is sustainable. Historically, several leverage ratios have been developed to measure the amount of debt a company bears and debt-to-equity ratio is one of the most common ratios.

Analyzing Debt/Equity

Debt-to-Equity Ratio = Total Liabilities/Shareholders’ Equity

This metric is a liquidity ratio that indicates the amount of financial risk a company bears. A company with a lower debt-to-equity ratio indicates improved solvency for a company.

As we are off to a strong start in the Q2 earnings season, investors must be eyeing companies that have historically exhibited solid earnings growth and are expected to do the same this time around. However, blindly pursuing high earnings yielding stocks might drain all your money before you know, if the stock bears a high debt-to-equity ratio.

Considering this, it will be wise for investors to select companies with low leverage. These are financially more secure and immune to financial bankruptcy.

And that's what we're screening for today…

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/312711/bet-on-these-5-low-leverage-stocks-for-safe-returns

Get the remaining stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Amedisys, Inc. (AMED) - free report >>

Louisiana-Pacific Corporation (LPX) - free report >>

Houlihan Lokey, Inc. (HLI) - free report >>